人际与社会节律治疗对成人双相II型抑郁症自杀意念的影响。

IF 4.6 2区 医学 Q1 PSYCHIATRY
Bridget C Bailey, Theresa J Early, Kathryn E Williams-Sites, Bailey Dyson, Holly A Swartz
{"title":"人际与社会节律治疗对成人双相II型抑郁症自杀意念的影响。","authors":"Bridget C Bailey, Theresa J Early, Kathryn E Williams-Sites, Bailey Dyson, Holly A Swartz","doi":"10.4088/JCP.24m15768","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Individuals with bipolar II disorder (BD II) have among the highest rates of suicide ideation (SI), attempts, and deaths. No studies to date have examined psychosocial treatment of SI in adults with BD II. The purpose of this study was to investigate whether patients with BD II depression receiving interpersonal and social rhythm therapy (IPSRT), an evidence-based psychotherapy for BD, experienced a decrease in SI, and whether this varied by use of adjunctive medication compared to IPSRT monotherapy.</p><p><p><b>Methods:</b> In a post hoc analysis of Swartz et al (2018), adults meeting <i>DSM-IV</i> criteria for BD II, currently depressed (n=92), were randomly assigned to receive IPSRT+placebo (IPSRT+P) or IPSRT+quetiapine (IPSRT+Q) and treated for 20 weeks. SI was assessed at baseline and weekly using the 17-item Hamilton Depression Rating Scale item 3. Multilevel logistic regression was used to model SI categorically.</p><p><p><b>Results:</b> The results demonstrate a decrease in odds of SI over time (OR=0.8719, 95% CI, 0.8166-0.9309, <i>P</i>≤.001), with a 13% decrease in the odds of having SI for each additional week of treatment. There was no significant difference between those receiving IPSRT+P vs IPSRT+Q.</p><p><p><b>Conclusions:</b> IPSRT has the potential to mitigate suicidal ideation in patients with BD II depression, regardless of whether they receive medication in addition to IPSRT. IPSRT alone may be a reasonable option to treat SI in an outpatient setting for some patients with BD II, especially those for whom medication is contraindicated or who prefer avoiding medication.</p><p><p><b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT01133821.</p>","PeriodicalId":50234,"journal":{"name":"Journal of Clinical Psychiatry","volume":"86 4","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of Interpersonal and Social Rhythm Therapy on Suicidal Ideation in Adults With Bipolar II Depression.\",\"authors\":\"Bridget C Bailey, Theresa J Early, Kathryn E Williams-Sites, Bailey Dyson, Holly A Swartz\",\"doi\":\"10.4088/JCP.24m15768\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> Individuals with bipolar II disorder (BD II) have among the highest rates of suicide ideation (SI), attempts, and deaths. No studies to date have examined psychosocial treatment of SI in adults with BD II. The purpose of this study was to investigate whether patients with BD II depression receiving interpersonal and social rhythm therapy (IPSRT), an evidence-based psychotherapy for BD, experienced a decrease in SI, and whether this varied by use of adjunctive medication compared to IPSRT monotherapy.</p><p><p><b>Methods:</b> In a post hoc analysis of Swartz et al (2018), adults meeting <i>DSM-IV</i> criteria for BD II, currently depressed (n=92), were randomly assigned to receive IPSRT+placebo (IPSRT+P) or IPSRT+quetiapine (IPSRT+Q) and treated for 20 weeks. SI was assessed at baseline and weekly using the 17-item Hamilton Depression Rating Scale item 3. Multilevel logistic regression was used to model SI categorically.</p><p><p><b>Results:</b> The results demonstrate a decrease in odds of SI over time (OR=0.8719, 95% CI, 0.8166-0.9309, <i>P</i>≤.001), with a 13% decrease in the odds of having SI for each additional week of treatment. There was no significant difference between those receiving IPSRT+P vs IPSRT+Q.</p><p><p><b>Conclusions:</b> IPSRT has the potential to mitigate suicidal ideation in patients with BD II depression, regardless of whether they receive medication in addition to IPSRT. IPSRT alone may be a reasonable option to treat SI in an outpatient setting for some patients with BD II, especially those for whom medication is contraindicated or who prefer avoiding medication.</p><p><p><b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT01133821.</p>\",\"PeriodicalId\":50234,\"journal\":{\"name\":\"Journal of Clinical Psychiatry\",\"volume\":\"86 4\",\"pages\":\"\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4088/JCP.24m15768\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4088/JCP.24m15768","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

目的:双相II型精神障碍(BD II)患者的自杀意念(SI)、自杀企图和死亡比例最高。到目前为止,还没有研究对成年双相障碍II患者的SI进行心理社会治疗。本研究的目的是调查接受人际和社会节律治疗(IPSRT)(一种基于证据的双相障碍心理治疗)的双相障碍II型抑郁症患者是否经历了SI的减少,以及与IPSRT单药治疗相比,使用辅助药物是否会有所不同。方法:在Swartz等人(2018)的事后分析中,符合DSM-IV双相障碍II标准的成年人,目前抑郁(n=92),随机分配接受IPSRT+安慰剂(IPSRT+P)或IPSRT+奎硫平(IPSRT+Q)治疗20周。在基线和每周使用17项汉密尔顿抑郁评定量表第3项评估SI。采用多水平逻辑回归对SI进行分类建模。结果:结果显示SI的几率随着时间的推移而降低(OR=0.8719, 95% CI, 0.8166-0.9309, P≤0.001),每增加一周治疗,SI的几率降低13%。IPSRT+P组与IPSRT+Q组之间无显著差异。结论:IPSRT有可能减轻BD II型抑郁症患者的自杀意念,无论他们是否在IPSRT之外接受药物治疗。对于一些II型BD患者,特别是那些有药物禁忌或不愿用药的患者,单独IPSRT可能是治疗SI的合理选择。试验注册:ClinicalTrials.gov标识符:NCT01133821。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of Interpersonal and Social Rhythm Therapy on Suicidal Ideation in Adults With Bipolar II Depression.

Objective: Individuals with bipolar II disorder (BD II) have among the highest rates of suicide ideation (SI), attempts, and deaths. No studies to date have examined psychosocial treatment of SI in adults with BD II. The purpose of this study was to investigate whether patients with BD II depression receiving interpersonal and social rhythm therapy (IPSRT), an evidence-based psychotherapy for BD, experienced a decrease in SI, and whether this varied by use of adjunctive medication compared to IPSRT monotherapy.

Methods: In a post hoc analysis of Swartz et al (2018), adults meeting DSM-IV criteria for BD II, currently depressed (n=92), were randomly assigned to receive IPSRT+placebo (IPSRT+P) or IPSRT+quetiapine (IPSRT+Q) and treated for 20 weeks. SI was assessed at baseline and weekly using the 17-item Hamilton Depression Rating Scale item 3. Multilevel logistic regression was used to model SI categorically.

Results: The results demonstrate a decrease in odds of SI over time (OR=0.8719, 95% CI, 0.8166-0.9309, P≤.001), with a 13% decrease in the odds of having SI for each additional week of treatment. There was no significant difference between those receiving IPSRT+P vs IPSRT+Q.

Conclusions: IPSRT has the potential to mitigate suicidal ideation in patients with BD II depression, regardless of whether they receive medication in addition to IPSRT. IPSRT alone may be a reasonable option to treat SI in an outpatient setting for some patients with BD II, especially those for whom medication is contraindicated or who prefer avoiding medication.

Trial Registration: ClinicalTrials.gov identifier: NCT01133821.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Psychiatry
Journal of Clinical Psychiatry 医学-精神病学
CiteScore
7.40
自引率
1.90%
发文量
0
审稿时长
3-8 weeks
期刊介绍: For over 75 years, The Journal of Clinical Psychiatry has been a leading source of peer-reviewed articles offering the latest information on mental health topics to psychiatrists and other medical professionals.The Journal of Clinical Psychiatry is the leading psychiatric resource for clinical information and covers disorders including depression, bipolar disorder, schizophrenia, anxiety, addiction, posttraumatic stress disorder, and attention-deficit/hyperactivity disorder while exploring the newest advances in diagnosis and treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信